18800-22-1 Usage
General Description
4-CHLORO-3-TRIFLUOROMETHYL-BENZENETHIOL is a chemical compound with the molecular formula C7H4ClF3S. It is a thiol compound, which means it contains a sulfur atom bonded to a hydrogen atom and an aromatic ring. The 4-chloro and 3-trifluoromethyl substituents on the benzene ring make this compound a highly reactive and useful intermediate in organic synthesis. It can be used for the creation of various pharmaceuticals, agrochemicals, and materials. Its unique properties also make it a useful reagent in organic chemistry, particularly in the synthesis of complex molecules. Additionally, it has been used as a ligand in coordination chemistry and as a building block in the preparation of specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 18800-22-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,8,0 and 0 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 18800-22:
(7*1)+(6*8)+(5*8)+(4*0)+(3*0)+(2*2)+(1*2)=101
101 % 10 = 1
So 18800-22-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H4ClF3S/c8-6-2-1-4(12)3-5(6)7(9,10)11/h1-3,12H/p-1
18800-22-1Relevant articles and documents
SUBSTITUTED PHENYL SULFONYL PHENYL TRIAZOLE THIONES AND USES THEREOF
-
Paragraph 0146, (2019/05/22)
The present disclosure relates to substituted phenyl sulfonyl phenyl triazole thiones, pharmaceutical compositions containing them, and methods of using them.
ARYL-AND HETEROARYL-SUBSTITUTED BENZENE DERIVATIVES AS MODULATORS OF PI3-KINASE SIGNALLING PATHWAYS
-
Paragraph 0179, (2014/03/21)
The present disclosure relates to certain aryl- or heteroaryl-substituted benzene derivatives, pharmaceutical compositions containing them, and methods of using them, including methods for modulating autophagy or preventing, reversing, slowing or inhibiting the PI3K-AKT-MTOR pathway, and methods of treating diseases that are associated with autophagy or the PI3K-AKT-MTOR pathway.
